This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Pvk Suresh Babu: Innovator in Hepatitis C Virus Inhibitors
Introduction
Pvk Suresh Babu is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for the Hepatitis C virus. With a total of 2 patents to his name, his work is recognized for its potential impact on public health.
Latest Patents
His latest patents focus on Hepatitis C virus inhibitors. These inhibitors are characterized by a general formula (I) and include compositions that comprise the compounds. The methods for using these compounds to inhibit HCV are also disclosed, showcasing the innovative approaches taken by Babu in combating this viral infection.
Career Highlights
Pvk Suresh Babu is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against Hepatitis C, a virus that affects millions worldwide.
Collaborations
Throughout his career, Babu has collaborated with esteemed colleagues such as Li-Qiang Sun and Eric Mull. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Pvk Suresh Babu stands out as a dedicated inventor in the pharmaceutical industry, particularly in the realm of Hepatitis C virus inhibitors. His contributions are vital to the advancement of medical science and the improvement of health outcomes for patients affected by this virus.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile